Abstract
The increasing prevalence of obesity has triggered intense research on its pharmacotherapy. Besides central neuroendocrine pathways, many peripheral endocrino-metabolic signals have been investigated, but only few are probably of some utility in weight loss. This review reports about ghrelin and other gastrointestinal peptides involved in hunger and satiety.
Keywords: Ghrelin, glucagon-like peptide 1, cholecystokinin, bombesin, (3-36) peptide YY
Mini-Reviews in Medicinal Chemistry
Title: Ghrelin and Other Gastrointestinal Peptides Involved in the Control of Food Intake
Volume: 7 Issue: 1
Author(s): F. Tassone, F. Broglio, L. Gianotti, E. Arvat, E. Ghigo and M. Maccario
Affiliation:
Keywords: Ghrelin, glucagon-like peptide 1, cholecystokinin, bombesin, (3-36) peptide YY
Abstract: The increasing prevalence of obesity has triggered intense research on its pharmacotherapy. Besides central neuroendocrine pathways, many peripheral endocrino-metabolic signals have been investigated, but only few are probably of some utility in weight loss. This review reports about ghrelin and other gastrointestinal peptides involved in hunger and satiety.
Export Options
About this article
Cite this article as:
Tassone F., Broglio F., Gianotti L., Arvat E., Ghigo E. and Maccario M., Ghrelin and Other Gastrointestinal Peptides Involved in the Control of Food Intake, Mini-Reviews in Medicinal Chemistry 2007; 7 (1) . https://dx.doi.org/10.2174/138955707779317795
DOI https://dx.doi.org/10.2174/138955707779317795 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cognitive Function and Heart Failure: The Role of the Adrenergic System
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Safety of SGLT2 Inhibitors in Patients with Diabetes Mellitus
Current Drug Safety Pharmacological Management of Cardiac Disease in Patients with Type 2 Diabetes: Insights into Clinical Practice
Current Vascular Pharmacology Analytical Procedures for Secondary Metabolites Determination: Recent Trends and Future Perspectives
Letters in Drug Design & Discovery Treatment of Type 1 Diabetic Patients with Glucagon-Like Peptide-1 (GLP-1) and GLP-1R Agonists
Current Diabetes Reviews Editorial (Application of a Multidisciplinary Approach to Alzheimers Disease to Develop Novel Drug Targets by Integrating Biomarkers, Imaging, Genetic and Molecular Strategies)
Current Alzheimer Research Diabetogenic Effects of Parthinium hysterophorous Induced Allergic Rhinitis
Inflammation & Allergy - Drug Targets (Discontinued) Contractile Mechanisms in Diabetes-Related Erectile Dysfunction
Current Pharmaceutical Design SUMOylation in Neurological Diseases
Current Molecular Medicine Mitochondrial Disorders in Adults
Current Molecular Medicine Sensors Based On Carbon Nanotubes and Their Applications: A Review
Current Nanoscience Abdominal Aortic Aneurysm: What About Screening?
Current Pharmaceutical Design Role of Physician Gender in the Quality of Care of Cardiometabolic Diseases
Current Pharmaceutical Design Relationships of Birthweight and Postnatal Growth with Metabolic Risk Factors in Junior School Children in Korea
Current Hypertension Reviews Genetic Mapping of Pharmacogenetic Regulatory Variation
Current Pharmaceutical Design Mouse Models as a Translational Platform for the Development of New Therapeutic Agents in Multiple Myeloma
Current Cancer Drug Targets GLUT4 Goes Abnormal: Disregulation of the Insulin-Responsive Glucose Transporter in Abnormal Metabolic States
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Hepatocellular Carcinoma: Beyond the Boundaries of Age
Anti-Cancer Agents in Medicinal Chemistry Cholecystokinin 1(A) Receptor Polymorphisms
Current Topics in Medicinal Chemistry Design of SGLT2 Inhibitors for the Treatment of Type 2 Diabetes: A History Driven by Biology to Chemistry
Medicinal Chemistry